NCT00276588View on ClinicalTrials.gov

Gemcitabine and Carboplatin Followed by Paclitaxel in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

March 31, 2007

Conditions

Lung Cancer

Interventions

DRUG

carboplatin

DRUG

gemcitabine hydrochloride

DRUG

paclitaxel

Trial Locations (2)

21201

Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore

21231-2410

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT00276588 - Gemcitabine and Carboplatin Followed by Paclitaxel in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter